The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niravbhai Jashubhai Patel
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niravbhai Jashubhai Patel, a non-promoter acquirer, purchased 113,245 equity shares (1.88%) of Rekvina Laboratories Ltd through an off-market deal on May 15-16, 2025. His stake in the company rose from 4.59% (276,675 shares) to 6.47% (389,920 shares), crossing the 5% disclosure threshold. The total equity share capital of the company stands at 60,28,000 shares, and the acquirer has filed this disclosure under Regulation 29(2) of the SEBI Takeover Regulations, 2011. Notably, the company's shares are currently suspended from trading on BSE.
This is a non-promoter off-market acquisition that pushes the buyer's holding past the 5% regulatory threshold, which could attract further market attention. With the stock already suspended on BSE, liquidity is severely limited and shareholders face significant uncertainty regarding price discovery and exit options.